Clinical genetic testing adoption across China's extensive hospital network is approaching what many industry observers characterize as an inflection point in 2026, as oncology genomic profiling, reproductive genetic testing, rare disease genetic diagnosis, and pharmacogenomic testing transition from specialized academic medical center services to mainstream clinical tools deployed across...

After three decades of scientific development, clinical trial setbacks, and renewed optimism cycles that have characterized the history of gene therapy, the field has entered what many observers believe is its definitive era of clinical validation and commercial success, with an unprecedented wave of regulatory approvals, transformative patient outcomes, and massive investment creating the...